To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: Vertex taps Bozic as CMO; plus Nektar, Sangamo, Ascletis, Neurocrine, Neovacs, Dyne, Avidity, Pulmotect, Adaptimmune and 4BIO

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said SVP and Head of Global Clinical Development Carmen Bozic will become EVP, global medicines development and medical affairs. She will take on the additional role of CMO on April 1 when Reshma Kewalramani leaves the position to succeed Jeffrey Leiden as president and

Read the full 486 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers